Liquidia Earnings
NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$0.77
Liquidia earnings summary
Liquidia is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $0.77. In its most recent report on Aug 12, 2026 (Q2 2026), LQDA posted EPS of $0.74. Revenue for the quarter was $171.7 million.
Across the last 16 reports, LQDA shares moved an average of 6.9% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
LQDA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 12, 2026 | — | $0.74 | — | -7.8% |
| May 11, 2026 | — | $0.52 | — | +7.1% |
| Mar 5, 2026 | — | $0.18 | — | +1.7% |
| Nov 3, 2025 | — | $-0.04 | — | +7.5% |
| Aug 12, 2025 | — | $-0.49 | — | +3.4% |
| May 8, 2025 | — | $-0.45 | — | +23.7% |
| Mar 19, 2025 | — | $-0.45 | — | -0.2% |
| Nov 13, 2024 | — | $-0.40 | — | +8.2% |
| Aug 7, 2024 | — | $-0.38 | — | +21.1% |
| May 13, 2024 | — | $-0.40 | — | -2.3% |
| Mar 13, 2024 | — | $-0.43 | — | +5.2% |
| Nov 7, 2023 | — | $-0.24 | — | +1.0% |
| Aug 10, 2023 | — | $-0.36 | — | -2.9% |
| May 8, 2023 | — | $-0.18 | — | +12.8% |
| Mar 20, 2023 | — | $-0.08 | — | +0.9% |
| Nov 8, 2022 | — | $-0.14 | — | -4.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.